Sri Lanka Consolidated Dossier Mandatory for New Applications from August 2025

1. Key takeaways

Since August 2025, all new medical device applications in Sri Lanka must be submitted as a Consolidated Dossier. This format merges the three stages of the Foreign Manufacturing Site Approval (FMSA), the Sample Import Licence (SIL) and the Product Registration Dossier (PRD) into a single submission, replacing the serial sequence of separate applications that applied before. The change reorganises how a project is filed, but it does not soften what has to be filed. The documentation requirements have not been relaxed: the dossier must be complete from day one. An incomplete package is rejected at acceptance, so the burden of completeness shifts entirely to the applicant before the Tuesday window is even reached.

• From August 2025, all new applications must be submitted in the consolidated dossier format.
• The consolidation combines the FMSA (where required), the SIL (where required) and the PRD into one submission.
• It replaces the previous process of serial, separately scheduled applications.
• Documentation requirements are unchanged, and a complete dossier must be prepared from the first day.
• Two official documents support the format: the Guideline for Consolidated Dossier New Application Submission and Evaluation and the Checklist for Document Accepting of Consolidated New Medical Device Applications, published by the NMRA.
• Dossier numbering distinguishes reliance, non-reliance and locally manufactured situations.

2. Legal basis

The consolidated dossier format is supported by official NMRA documents rather than by any relaxation of requirements. The table below summarises what the format changes, what it leaves unchanged, and where each element is documented. Applicants should read it together with the two official NMRA documents named above, because it is those documents that the acceptance desk works through item by item.

Two points deserve emphasis before the table. First, the consolidation applies to all new applications, which means legacy projects planned under the old serial process must be re-planned if they have not yet been filed. Second, the three-part structure (FMSA, SIL, PRD) does not change what each part contains; it only changes the moment at which the parts must all be ready.

3. Expert insights

Insight one: what is consolidated is the act of submission, not the scope of review. The documents for all three stages still have to be submitted in full; what disappears is the staged scheduling of separate filings. The direct effect on applicants is that the front-end documentation workload is brought forward all at once. Instead of spreading site, sample and product work across several application cycles, the applicant must arrive at the acceptance window with every part of the file ready, which changes how the project must be staffed and sequenced.

Insight two: the consolidated dossier narrows the room for submitting first and completing later. Under the older pattern, an applicant could file part of the material and supplement the rest afterwards. Under the consolidated format, completeness is checked item by item against the checklist at acceptance, and an incomplete dossier is simply not accepted. There is no longer a practical grace period in which missing documents can be quietly supplied after the file has been handed over, so every gap in the package translates directly into a lost week.

Insight three: the change reshapes the resource curve of the project. Preparation of technical documentation, quality certificates and label artwork should be moved entirely ahead of the submission date, rather than invested in batches as each stage opens. Budget and personnel that used to be spread across the old multi-application cycle must now be concentrated before the single consolidated filing, which is a planning challenge as much as a regulatory one.

4. Practical recommendations

• Build a pre-submission completeness self-check sheet: break the GL-034 and F-MDR-046 checklists into individually tickable items.
• Run the full self-check once before the official submission and keep a record of the check as evidence.
• Fix any gaps found in the self-check immediately, so that deficiencies are closed before the file reaches the acceptance desk rather than after.
• Confirm that the FMSA, SIL and PRD parts are all integrated in one dossier and that the applicable dossier numbering category (reliance, non-reliance or local manufacture) has been selected.
• Keep the completed online application form ready before the physical filing, since it is a precondition for acceptance.
• Book the submission into the single Tuesday window of the week, because an incomplete or late file means waiting another full week.
• Assign one named owner to the consolidated dossier, since the FMSA, SIL and PRD parts now mature together and a single accountable owner prevents parts drifting out of sync.
• Review label artwork and quality certificates against the checklist before printing, because reprinting after a rejected acceptance costs another weekly cycle.

5. Verification checklist

• □ The FMSA, SIL and PRD parts have been integrated as required for the consolidated dossier
• □ The current official checklist has been used for a full self-check
• □ The online application form has been completed
• □ The dossier numbering category has been confirmed (reliance, non-reliance or local manufacture)
• □ Physical submission has been arranged in the Tuesday 9:00 to 15:00 window
• □ The self-check record has been retained in the project file
• □ The dossier owner has confirmed that all three parts were finalised before the submission date

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across South Asia, including Sri Lanka. Our team prepares dossiers to NMRA expectations, manages submissions and deficiency responses, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Regulatory information verified as of 28 October 2026.